Publications by authors named "Armandina Miranda"

Background: The α-Major Regulatory Element (α-MRE), also known as HS-40, is located upstream of the α-globin gene cluster and has a crucial role in the long-range regulation of the α-globin gene expression. This enhancer is polymorphic and several haplotypes were identified in different populations, with haplotype D almost exclusively found in African populations. The purpose of this research was to identify the HS-40 haplotype associated with the 3.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed samples from 192 patients, discovering over 5 million high-quality genetic variants and identifying specific genes associated with worsening vaso-occlusive crises (VOC) and lower fetal hemoglobin (HbF) levels.
  • * This research highlights the complex genetic factors influencing SCA symptoms and represents the first detailed investigation of its clinical variations in Angola, suggesting potential genetic modifiers related to patient phenotypes.
View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on Angolan children aged 3 to 12 with Sickle Cell Anemia (SCA), assessing their response to a 12-month hydroxyurea (HU) treatment and its potential side effects.
  • - Out of 215 enrolled patients, 141 completed the treatment, showing a significant decrease in clinical events like blood transfusions (53.4% reduction) and hospitalizations (47.1% reduction), with a mean increase in fetal hemoglobin (HbF) of 11.9%.
  • - The results indicated that while there was variability in treatment response among patients, HU was generally well-tolerated with no major clinical side effects, highlighting its potential to improve survival among children with S
View Article and Find Full Text PDF

Sickle cell anemia (SCA) causes a long-standing vascular inflammation state, leading to endothelial dysfunction and chronic overexpression of several adhesion molecules, which contributes to acute and constant vaso-occlusive (VOC) episodes. It has been demonstrated that hydroxyurea (HU) can reduce VOC events, organ damage, blood transfusions, and even the adhesion properties to endothelial cells of SCA subjects. Due to VOC episodes, these patients are also more susceptible to recurrent bacterial translocation and dysbiosis.

View Article and Find Full Text PDF

Sickle cell anemia (SCA) is an inherited disease affecting the hemoglobin that is particularly common in sub-Saharan Africa. Although monogenic, phenotypes are markedly heterogeneous in terms of severity and life span. Hydroxyurea is still the most common treatment for these patients, and the response to treatment is highly variable and seems to be an inherited trait.

View Article and Find Full Text PDF

Sickle cell disease (SCD) is one of the most common genetic conditions worldwide. It can contribute up to 90% of under-5 mortality in sub-Saharan Africa. Clinical manifestations are very heterogeneous, and the intestinal microbiome appears to be crucial in the modulation of inflammation, cell adhesion and induction of aged neutrophils, the main interveners of recurrent vaso-occlusive crisis.

View Article and Find Full Text PDF

Sickle cell anemia (SCA) is an inherited hematological disorder and a serious global health problem, especially in Sub-Saharan Africa. Although hydroxyurea (HU) is the leading treatment for patients with SCA, its effects on the gut microbiome have not yet been explored. In this context, the aim of this study was to investigate this association by characterizing the gut microbiome of an Angolan SCA pediatric population before and after 6 months of HU treatment.

View Article and Find Full Text PDF

Background: Sickle cell anemia (SCA) is an inherited blood disorder that affects over 300,000 newborns worldwide every year, being particularly prevalent in Sub-Saharan Africa. Despite being a monogenic disease, SCA shows a remarkably high clinical heterogeneity. Several studies have already demonstrated the existence of some polymorphisms that can provide major clinical benefits, producing a mild phenotype.

View Article and Find Full Text PDF

The aim of this study was to explore the association between alpha-thalassemia, fetal hemoglobin, hematological indices, and clinical adverse events in Angolan sickle cell disease pediatric patients. A total of 200 sickle cell disease (SCD) children were sampled in Luanda and Caxito. A venous blood sample was collected and used for hematological analyses, fetal hemoglobin quantification, and genotyping of 3.

View Article and Find Full Text PDF

Inherited deletions of α-globin genes and/or their upstream regulatory elements (MCSs) give rise to α-thalassemia, an autosomal recessive microcytic hypochromic anemia. In this study, multiplex ligation-dependent probe amplification performed with commercial and synthetic engineered probes, Gap-PCR, and DNA sequencing were used to characterize lesions in the sub-telomeric region of the short arm of chromosome 16, possibly explaining the α-thalassemia/HbH disease phenotype in ten patients. We have found six different deletions, in heterozygosity, ranging from approximately 3.

View Article and Find Full Text PDF

The phenotype of increased Hb A2 typical of beta-thalassaemia (beta-thal) carriers can be reduced to normal or borderline values because of the co-inheritance of a delta-globin gene (HBD, MIM #142000) mutation, which may lead to misinterpretation of diagnostic results. To know the spectrum of delta-globin mutations in the Portuguese population we performed a mutational analysis of the delta-globin gene in a group of 51 Portuguese beta-thal carriers presenting microcytosis, hypochromia and a normal/borderline Hb A2 level and in another group of 15 individuals suspected to have delta-globin structural abnormalities. The heterozygosity for the beta(+)IVS-I-6T-->C (HBB:c.

View Article and Find Full Text PDF

We report a novel mutation in the alpha2-globin gene, codon 35 (T-->C), detected in two unrelated Portuguese families. This mutation gives rise to a previously undescribed hemoglobin (Hb) variant, which we named Hb Evora. This variant seems to be responsible for the alpha-thalassemia phenotype present in its carriers.

View Article and Find Full Text PDF

Hemoglobin (Hb) Loves Park [beta68 (E12) Leu-->Phe] was identified in a 2-year-old Portuguese boy with anemia, microcytosis, and hypochromia. This Hb variant was detected by isoelectric focusing and quantified by reverse-phase high-performance liquid chromatography (HPLC) (48.4%), and the DNA mutation was identified by HBB (beta-globin gene) sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated the safety and effectiveness of hydroxyurea (HU) in children with severe sickle cell anemia at a Portuguese hospital over a 24-month period.
  • Nine children, aged 8 to 16, participated and underwent treatment with HU, which increased their fetal hemoglobin (Hb F) levels significantly from 7.0% to 13.7%.
  • Results showed a substantial decrease in complications, including an 80% reduction in vaso-occlusive crises, along with fewer hospital visits and blood transfusions, without significant side effects.
View Article and Find Full Text PDF

Hereditary hemochromatosis (HH) is an autosomal recessive disorder of iron metabolism characterized by increased iron absorption and progressive storage resulting in organ damage. HFE gene mutations C282Y and H63D are responsible for the majority of HH cases. A third HFE mutation, S65C, has been associated with the development of a mild form of hemochromatosis.

View Article and Find Full Text PDF

Hb Yaoundé [beta134(H12)Val-->Ala] is a rare, silent and asymptomatic hemoglobin (Hb) variant. It was previously reported in a Black man from Cameroon, in association with Hb Kenitra [beta69(E13)Gly-->Arg], and was subsequently found and described as Hb Mataro in a sub-Saharan child. To date, Hb Yaoundé has not been described in Caucasian people and molecular studies have never been performed.

View Article and Find Full Text PDF
Article Synopsis
  • Molecular studies of hemoglobin Porto Alegre in Portugal and Brazil show a specific mutation (beta9 Ser->Cys) linked to the Mediterranean haplotype I and a new polymorphism (codon 27, GCC->GCT).
  • This mutation likely originated from a single event within the Portuguese population.
  • Historical data suggests that this mutation spread to South America, specifically Brazil, following its emergence.
View Article and Find Full Text PDF

Homozygosity or compound heterozygosity for beta(0)-thalassemia mutations most commonly results in a transfusion-dependent thalassemia major phenotype. In this report, we describe a 55-year-old male, from Guinea-Bissau, that had been asymptomatic and never transfused until being admitted to hospital with anemia, fever, splenomegaly, and asthenia. Following hospital admission, HIV-2 and Mycobacterium tuberculosis infections were diagnosed, and biochemical and molecular studies revealed homozygosity for beta(0)-thalassemia.

View Article and Find Full Text PDF